Unlike GLP-1 receptor agonists, which primarily regulate appetite and glucose metabolism, CD44 inhibition addresses obesity through a distinct mechanism by directly impairing adipogenesis.

They previously identified the cell-surface receptor on these HSCs, called HCELL, a glycosylated variant of the transmembrane protein CD44, responsible for the homing of the cells from the blood ...